VEGFA and diabetic macular edema: Clinically, a randomized controlled trial conducted in patients with diabetic macular edema (DME), which was induced by ROS and DR inflammation, found that the combined administration of oral DHA and intravitreal anti-VEGF significantly improved DME compared with a single treatment with anti-VEGF drugs.